< Back to previous page
Organisation
Nuclear Medicine & Molecular Imaging
Division
Main organisation:Department of Imaging & Pathology
Lifecycle:1 Jul 1977 → Today
Organisation profile:
Tomographic evaluation of tracer distribution (PET, SPECT). - Medical Imaging: acquition, reconstruction PET and SPECT. - Metabolic Imaging in acute and chronic heart disease. - Metabolic Imaging in oncology and inflammation - Neuroactivation, protein deposit and receptor studies of the brain. - Radio immunotherapy. - Molecular imaging - Brain imaging. - Image registration (PET, SPECT, MRI, CT).
Keywords:Nuclear medicine, Radiopharmacy, SPECT, PET, Medical Imaging
Disciplines:Medical imaging and therapy, Medicinal products
Current researchers
1 - 10 of 25 results
- Koen Van Laere (Responsible)
- Niloefar Ahmadi Bidakhvidi (Member)
- Kristof Baete (Member)
- Charles Carron (Member)
- Dayana Castillo Seoane (Member)
- Christopher Cawthorne (Member)
- Sofie Celen (Member)
- Christophe Deroose (Member)
- Masoud ElhamiAsl (Member)
- Prodromos Gavriilidis (Member)
Projects
1 - 10 of 123
- Prospective clinical diagnostic performance of the novel fibroblast imaging tracer 18F-AlF-FAPI-74 versus standard of care 18F-FDG PET/CT in inflammatory disorders and fever/inflammation of unknown origin.From16 Apr 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Towards mechanistic biomarkers for amyotrophic lateral sclerosisFrom1 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Development and preclinical evaluation of diagnostic and therapeutic radiopharmaceuticals for pancreatic cancerFrom2 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Multicenter validation trial of [18F]AlF-FAPI-74 for PET imaging of cancer-associated fibroblasts through fibroblast activation protein inhibitors (FAPI) in digestive tumorsFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The role of cerebral imaging in the diagnosis, management and prognosis of possible non-convulsive status epilepticus.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- A whole-body physiologically based pharmacokinetic model for personalized 161Tb-PRRTFrom1 Oct 2023 → TodayFunding: SCK (Study Centre Nuclear Energy)
- Prospective head-to-head comparison of cardiac [18F]-MFBG PET versus [123I]-MIBG SPECT in the differentiation between Parkinson’s disease and multiple system atrophy and between dementia with Lewy bodies and Alzheimer’s disease.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The role of cerebral imaging in the diagnosis, management and prognosis of possible non-convulsive status epilepticusFrom1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- In vivo PET of synaptic density in cognitive disorders: prospective evaluation of neuronal dysfunction and relation to symptomatology.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The role of cerebral functional (FDG-PET, arterial spin imaging and CT perfusion), structural and spectral imaging in the diagnosis, management and prognosis of status epilepticus: a prospective study in patients with the ictal-interictal continuum and normal EEG.From1 Oct 2023 → TodayFunding: Fund Recuperation Fiscal Exemption
Publications
41 - 50 of 1555
- Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion(2016)
Authors: Felix Mottaghy
Pages: 240 - 248 - Evidence of a modality-dependent role of the cerebellum in working memory? An fMRl study comparing verbal and abstract n-back tasks(2009)
Authors: Felix Mottaghy
Pages: 2073 - 2082 - Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals(2022)
Authors: Michel Koole
- A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT)(2022)
Authors: Kaat Spoormans, Michel Koole
- Cu-64-Labeled Affibody Molecules for Imaging of HER2 Expressing Tumors(2010)
Authors: Olivier Gheysens
Pages: 316 - 324 - Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact(2021)
Authors: Donatienne Van Weehaeghe
Pages: 958 - 978 - Total Body Metabolic Tumor Response in ALK Positive Non-Small Cell Lung Cancer Patients Treated with ALK Inhibition
Authors: Michel Koole
- Variability of BOLD response evoked by foot vibrotactile stimulation: Influence of vibration amplitude and stimulus waveform
Authors: Felix Mottaghy
Pages: 504 - 510 - Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Authors: Felix Mottaghy
- Estimation of and correction for finite motion sampling errors in small animal PET rigid motion correction
Authors: A Miranda, S Staelens, Sigrid Stroobants, J Verhaeghe
Pages: 505 - 518